{"id":425918,"date":"2024-10-20T06:59:20","date_gmt":"2024-10-20T06:59:20","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-23-30453001-dc\/"},"modified":"2024-10-26T13:11:58","modified_gmt":"2024-10-26T13:11:58","slug":"bsi-23-30453001-dc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-23-30453001-dc\/","title":{"rendered":"BSI 23\/30453001 DC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions and abbreviated terms 3.1 Terms and definitions 3.2 Abbreviated terms <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 4 Justification for a clinical investigation 5 Ethical considerations 6 General requirements 6.1 General <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 6.2 Design of a clinical investigation 6.2.1 Requirements for all types of IOL 6.2.2 Additional requirements for toric IOLs (TIOL) 6.2.3 Additional requirements for Simultaneous Vision IOL (SVIOL) including MIOL, EDF and FVR lenses <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 6.2.4 Additional requirements for accommodating IOLs (AIOL) 6.2.5 Additional requirements for anterior chamber IOLs 6.3 Characteristics of clinical investigations 6.3.1 General 6.3.2 Characteristics to be studied for all types of IOL <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 6.3.3 Additional characteristics to be studied for toric IOL 6.3.4 Additional characteristics to be studied for SVIOLs 6.3.5 Additional characteristics to be studied for accommodating IOL <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 6.3.6 Additional characteristics applying to anterior chamber IOLs 6.3.7 Additional characteristics 6.4 Duration of the investigations 6.5 Enrolment <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 6.6 Bilateral implantation 6.7 Surgical technique 6.8 Examination and treatment of subjects 6.9 Adverse events reports 6.10 Inclusion and exclusion criteria 6.10.1 General 6.10.2 General inclusion criteria <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 6.10.3 Additional inclusion criteria for toric IOL 6.10.4 General exclusion criteria 6.10.5 Additional exclusion criteria for simultaneous vision IOL 6.10.6 Additional exclusion criteria for anterior chamber IOL <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | Annex\u20acA (normative) General elements in the clinical investigation of IOLs <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | Annex\u20acB (informative) Additional elements for the clinical investigation of toric IOLs <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | Annex\u20acC (informative) Additional elements for the clinical investigation of simultaneous vision (SVIOL) IOLs <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Annex\u20acD (informative) Additional elements for the clinical investigation of accommodating IOLs <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | Annex\u20acE (informative) Evaluation of post operative adverse events and visual acuity rates <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | Annex\u20acF (informative) Clinical tests <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | Annex\u20acG (informative) Statistical methods and sample size calculations <\/td>\n<\/tr>\n | ||||||
59<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" BS EN ISO 11979-7. Ophthalmic implants. Intraocular lenses – Part 7. Clinical investigations of intraocular lenses for the correction of aphakia<\/b><\/p>\n |